Serena Spudich MD, MA
Associate Professor of Neurology; Division Chief, Neurological Infections & Global Neurology
HIV; AIDS; Central nervous system inflammation; Viral compartmentalization; Acute infection; HIV reservoirs; Magnetic resonance spectrocsopy; Diffusion tensor imaging; Neural markers; Cerebrospinal fluid biomarkers
Our group’s clinical and translational research focuses on characterization of the central nervous system in HIV-infected patients in an effort to understand and treat the processes underlying damage to the nervous system by HIV, as well as establishment and reduction of potential central nervous system reservoirs for infection.
Our current program employs a multidisciplinary approach to patient-oriented research in neuro-HIV, through active collaborations with researchers in immunology, radiology, neuropsychology, virology, and molecular biomarkers. We apply these methods to novel studies of patients that may inform about neuroprotection and neuropathogenesis in HIV, including individuals with acute or early HIV infection, elite controllers who maintain undetectable viral loads in the absence of antiretroviral therapy, and patients at different stages of treatment with antiretroviral therapy. We are also performing clinical studies aimed to examine and/or reduce early establishment of central nervous system reservoirs for HIV infection.
Our studies focus on subjects recruited in urban centers in the US and other international sites including Bangkok, Thailand. Broader involvement with the design and implementation of multicenter studies relevant to neuro-HIV is facilitated by Dr. Spudich’s leadership position within the international AIDS Clinical Trials Group (ACTG), facilitated by an affiliation with the Cornell AIDS Clinical Trials Unit.